Clear Harbor Asset Management, LLC Arbutus Biopharma Corp Transaction History
Clear Harbor Asset Management, LLC
- $1.79 Billion
- Q3 2025
A detailed history of Clear Harbor Asset Management, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 74,761 shares of ABUS stock, worth $361,843. This represents 0.02% of its overall portfolio holdings.
Number of Shares
74,761
Previous 79,761
6.27%
Holding current value
$361,843
Previous $246,000
37.8%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding ABUS
# of Institutions
184Shares Held
118MCall Options Held
1MPut Options Held
478K-
Morgan Stanley New York, NY24.2MShares$117 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$64.6 Million14.31% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$55.9 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY10.4MShares$50.5 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$44 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $726M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...